PFIZER
|
The Current P/B Ratio of PFIZER is 5.10.
| Share Price | ₹4,704.0 | Mar 11,2026 |
| Market Cap | ₹21,497.3 Cr | |
| Book Value | ₹4,217.4 Cr | Mar2025 - Standalone Results |
| Price/Book | 5.10x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of PFIZER
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹21,497.3 Cr] as on Mar 11,2026
(/) Book Value [ ₹4,217.4 Cr] based on Mar2025 - Standalone Results
(=) P/B Ratio [ 5.10x ]
Thus, for PFIZER , the investors are currently willing to pay '5.10 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of PFIZER !
The chart below summarizes the trend in P/B Ratio of PFIZER over the last five years.
Historical PB (Price/Book ) ratio chart of PFIZER
PB Ratio Performance Analysis for PFIZER
- PFIZER 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 6.04x.
- PFIZER 's operated at median p/b ratio of 5.34x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PFIZER 's p/b ratio peaked in Mar2021 at 8.64x.
- PFIZER 's p/b ratio hit its five-year low in Mar2025 of 4.34x.
How does PFIZER 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| PFIZER | 4,217.41 | 5.10 | 21,497.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 6.06 | 437,855.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 11.26 | 168,550.0 |
| CIPLA LTD | 31,079.30 | 3.46 | 107,427.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 19.75 | 149,906.0 |
| DR REDDYS LABORATORIES LTD | 33,404.90 | 3.31 | 110,632.0 |
| MANKIND PHARMA LTD | 14,288.70 | 6.48 | 92,610.8 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 3.87 | 92,774.8 |
| LUPIN LTD | 17,119.50 | 6.26 | 107,199.0 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.32 | 75,771.4 |
| ABBOTT INDIA LTD | 4,204.27 | 13.75 | 57,821.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs PFIZER 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.32x |
| Max industry PB | 19.75x |
| Median industry PB | 6.06x |
| Average industry PB | 7.42x |
You may also like the below Video Courses